Conclusions Noninvasive imaging of neurohumoral upregulation in remodeled myocardium
suggests that an imaging strategy can be developed for predicting the rate of remodeling …

Cardiac left ventricular (LV) remodeling is the final common pathway of most primary
cardiovascular diseases that manifest clinically as heart failure (HF). The more advanced the …

Heart failure (HF) is a major problem, with a high prevalence, morbidity, mortality, and cost,
and is expected to become more widespread. Radionuclide imaging currently plays an …

123 I-metaiodobenzylguanidine (123 I-MIBG) imaging is a tool for evaluating one of the
fundamental pathophysiologic abnormalities seen in heart failure (HF), that of an …

Left ventricular remodeling is a key determinant of the clinical course and outcome of
systolic heart failure. The myocardial renin–angiotensin system (RAS) has been closely …

Molecular imaging can detect and quantify pathophysiological processes underlying heart
failure, complementing evaluation of cardiac structure and function with other imaging …

The management of patients with heart failure (HF) is challenging and requires the
integration of clinical skills and accurate ancillary tests for the correct diagnosis and …

Left ventricular (LV) remodeling is a major determinant of the clinical course and outcome of
systolic heart failure (HF). Activation of neurohormonal and inflammatory cytokine pathways …

The need for noninvasive assessment of cardiac volumes and ejection fraction (EF) ushered
in the use of cardiac imaging techniques in heart failure (HF) trials that investigated the roles …

Congestive heart failure (CHF) is a clinical syndrome of impaired cardiac contractile function
resulting from structural damage, and is characterized by a vicious cycle in which reduced …